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The  folding  of  maltose-binding  protein,  a peri- 
plasmic  protein  in Escherichia  coli, was shown to pro- 
ceed  through  the  same rate-limiting step whether  fold- 
ing occurred  in  the cell under  physiological  conditions 
or in vitro in  the  absence  of  other  proteins.  Four  species 
of  maltose-binding  protein  containing  aminoacyl  sub- 
stitutions identified as decreasing  the  rate  of  folding 
of  the  protein in  vivo were purified,  and  their  denatur- 
ant-induced  folding  transitions were analyzed  by mon- 
itoring  the  intrinsic  fluorescence  of  tryptophan. In all 
four cases the rate of  folding in vitro was slower than 
that  of  the wild-type maltose-binding  protein;  thus  the 
same step determines  the rate of  folding in  vivo and 
in vitro. Furthermore, examination of the three-di- 
mensional  structure  of  maltose-binding  protein as de- 
termined by x-ray crystallography (F. Quiocho, per- 
sonal communication;  Spurlino, J. C., Lu, G.-Y., and 
Quiocho,  F. A. (1991) J. Biol. Chem. 266,5202-5219) 
indicates  that all 4 of  the  residues  identified as crucial 
to  folding lie in  one  structural  element  of  the native 
protein. We conclude  that  the rate-limiting step  both 
in  vivo and in  vitro involves formation  of this element 
of structure. 
The information governing the  intricate folding of polypep- 
tides  into compact structures resides in the primary sequence 
of the aminoacyl residues as is clearly evidenced from the 
ability of isolated polypeptides to achieve their  native confor- 
mation spontaneously in vitro (1). Even so in the complex 
milieu of the cellular cytosol the acquisition of the correct 
structure often depends upon facilitation by a family of pro- 
teins  termed chaperones (2). The need for chaperones can be 
rationalized by the obvious differences between the conditions 
in vitro and in vivo. The investigator has control over the 
protein  concentration, ionic conditions, and  temperature in 
vitro so that  the system can be optimized to favor folding. In 
the cell where protein  concentration is high, the polypeptide 
has many opportunities to  enter nonproductive interactions 
that would interfere with folding. Two fundamentally differ- 
ent models have been proposed to account for the action of 
chaperones. First, it is possible that  they actively participate 
in the folding reaction much as enzymes act to catalyze 
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chemical reactions (3-6). In one version of this model the 
chaperone would have affinity for an intermediate  in folding 
and upon binding would effect a decrease in the activation 
energy along the folding pathway, thereby increasing the rate 
constants for the reaction. Another proposal for active partic- 
ipation is that  the chaperone binds  and releases portions of 
the polypeptide in  an ordered way to direct the folding path- 
way. A second model is that chaperones do not actively 
modulate folding but enhance the flux through the proper 
folding pathway by controlling competing processes that lead 
to aggregation (7-12). Intermediates along folding pathways 
often display hydrophobic surfaces and  are prone to aggrega- 
tion at high concentration. Thus a simple way to facilitate 
folding of a monomeric protein is to bind the intermediate 
and lower its concentration, thereby decreasing the rate of 
bimolecular processes such as aggregation with no  effect  on 
the  rate of unimolecular folding. Higher order reactions such 
as the formation of oligomers could also be favored if the 
folding reaction were to proceed on the surface of the  chap- 
erone and  the polypeptide were released in a state  that would 
oligomerize more rapidly than  it would aggregate. It should 
be noted that folding on the surface does not necessarily 
require participation of the chaperone in a catalytic sense. 
The reaction might proceed at  the same rate  as  it would in 
free solution if the competing aggregation pathway could be 
blocked. 
The difference in these two  models is important because of 
the implications for any  attempt  to elucidate the pathway of 
folding. The consensus, based on scrutiny of a tremendous 
body of data gathered i n  vitro with many proteins, is that  the 
spontaneous folding observed proceeds via defined interme- 
diates (13, 14). A crucial question is are the pathways and 
intermediates we can define i n  vitro using the powerful bio- 
physical tools available to us the pathways utilized in vivo or 
do chaperones act  to direct polypeptides along different path- 
ways? 
There  is much evidence obtained from studies of chaperone- 
mediated folding i n  vitro that  the mode of action is one of 
blockage of aggregation (7-12);  however, Hart1 and colleagues 
(6) have shown that changes do  occur  while polypeptides are 
tethered to  the chaperone. Since the elegant biophysical tech- 
niques used in folding studies  cannot be applied in vivo, it is 
difficult to relate the i n  vitro data  to occurrences in the cell. 
We have taken advantage of the relationship between folding 
and export of maltose-binding protein to identify alterations 
of maltose-binding protein that affect the step that deter- 
mines the  rate of folding in vivo, and we demonstrate that  the 
same step in folding is rate-determining in vitro. Examination 
of the location in the native  structure of the residues that  are 
altered indicates that  the structure of the transition  state in 
the rate-limiting  step is near the native state. 
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EXPERIMENTAL  PROCEDURES 
Materials-Urea (ultrapure) was purchased from Boehringer 
Mannheim, HEPES  and Trizma from Sigma, and  the amylose resin 
from New England Biolabs. [?3]Methionine (1000 Ci/mmol) was 
purchased from Du Pont-New England Nuclear. 
Bacterial Strains-For ease of discussion, throughout the  text we 
shall designate alleles of malE, the gene encoding maltose-binding 
protein, and  their corresponding protein products according to  the 
aminoacyl substitution found in the polypeptide. The first letter 
following m l E  represents the aminoacyl residue found in the wild- 
type protein and  the number indicates the position of the substitution. 
If the position of the substitution  is in  the leader peptide it is given 
in parentheses as a negative number. The position immediately 
preceding the first residue of the mature is designated “-1.” The 
letter following the number represents the aminoacyl residue found 
in place of the wild-type residue. In some cases, we also indicate the 
name given to  the alleles at  the time of isolation. 
All strains  are derivatives of Escherichia coli K-12. An isogenic 
derivative of MC4100 (F-AIacU169 araD139 rpsL.150 thi flbB5301 
deo-7 ptsF25 relA1) (15) carries the double mutation mdE 19-1, 
malE G19C (hereafter, malE M(-8)R, malE G19C) (16). KM4 and 
KM19  were provided by  M. Manson and  are isogenic derivatives of 
strain “110 (F- thr-l(Am)  kuB6 his-4 thi-1 rpsL136 ara-14 lacy1 
mtl-1 xyl-1 t o d 3 1  tsx-78 malT-1 zjb-729::TnlO) containing the 
malE454 (malE  D55N) and malE469 (malE T3451) alleles, respec- 
tively (17). Plasmids carrying malE, malE A276G, malE Y283D and 
double mutations malE 16-1  (malE Tf-ll)K), malEA276Gand  malE 
18-1 (malE M(-9)R), malE A276G are derivatives of pBAR43 (18), 
and plasmids carrying the alleles malE T3451, malEl4-1 (mZE 
Af-13)E) (19), malE Tf-ll)K (19), malE V8G, and  the double mu- 
tations malE T(-ll)K, malE V8G and malE A(-13)E, malE T3451 
are derivatives of pJF2 (20). All  genes are expressed under the control 
of the lacUV5 promoter. Since the host strain does not  contain the 
lac repressor on a high copy number, plasmid induction was not 
necessary to achieve high levels of expression. The host strain for the 
plasmids, BAR1091 a derivative of MC4100, carries  a deletion in the 
malE gene  (AmalE312 (20)). 
Selection of Suppressors-The plasmid carrying the wild-type malE 
allele, pmalE, or  pmalE. SpeI was mutagenized with hydroxylamine 
in an attempt to increase the probability of isolating mutants of 
interest.  A sample of the mutagenized plasmid was used to demon- 
strate  that  the mutagenesis was effective; the frequency of appearance 
of colonies with a Mal- phenotype was approximately 1%. Neverthe- 
less, the base changes in the suppressors isolated as described below 
seem to be spontaneous changes that did not result from the muta- 
genesis, since they  are not characteristic of treatment with hydrox- 
ylamine (21). Following mutagenesis, the fragment containing the 
mature portion of malE was excised from the plasmid using the 
restriction sites BglII (after 119th codon of the sequence encoding 
the mature region of maltose-binding protein) and  PstI, or  SpeI (the 
SpeI site was constructed between the  6th  and 7th codon and does 
not alter the aminoacyl residues) and PstI (see  Fig. 1)  and ligated to 
the smaller fragment of pmalE A(-13)E generated by digestion with 
the same restriction enzymes. In  this way the mutagenized mature 
portion was expressed linked to a defective leader. Suppressors of the 
export defect caused by the mutated leader were identified by com- 
parison of the color of colonies on MacConkey plates containing 
maltose. Location of the suppressor change as within the mature was 
confirmed by excising the small BglII-NcoI (cleavage after 2nd base 
of 320th codon) fragment and ligating it  to  the large fragment of 
Ecq RI l e j d e r  
Pst 
FIG. 1. Structure of plasmid pmalE. SpeI used in isolation 
of suppressors. Sites for the restriction enzymes used are indicated. 
pmalE A(-13)E digested with BglII andNcoI. Most of the suppressors 
initially identified carried mutations located outside the mature  por- 
tion of the gene and affected the level of expression. The search 
resulted in identification of two mutations  in the portion of the gene 
encoding the mature protein: malE Y283D and malE A276G. The 
base changes in malE Y283D (TAT  to GAT) and malE A276G (GCG 
to GGG)  were identified by determining the nucleotide sequence of 
the entire BglII-NcoI region of the suppressor genes. The sequencing 
reactions were carried out using the  T7 DNA polymerase kit from 
United States Biochemical Corp. as suggested by the manufacturer. 
The DNA primers were synthesized using an oligonucleotide synthe- 
sizer (Pharmacia Gene Assembler). 
Kinetics of Processing of Precursor Maltose-binding Protein-Cells 
were grown to a density of 2.5 X 10’ cells/ml in M9 minimal salts 
medium (21) supplemented with 4 X vitamin B1, 0.4% glycerol, 
and 0.2% maltose and radiolabeled for 15 s by the addition of 60 pCi/ 
ml of [36S]methionine and nonradioactive methionine to give a  final 
concentration of 30 nM methionine. At 15 s, nonradioactive methio- 
nine was added to give a  final  concentration of 100 p ~ ,  and at  the 
times indicated 10’ cells were taken directly into trichloroacetic acid 
to give a  final  concentration of 5% trichloroacetic acid. The samples 
binding protein as described (22). The immunoprecipitated samples 
were processed for immunoprecipitation with antiserum to maltose- 
were analyzed by SDS, 11% polyacrylamide gel electrophoresis. The 
gels  were soaked in 1 M sodium salicylate (pH 5.8) before they were 
dried and overlaid with x-ray film for fluorography. The bands of 
maltose-binding protein at  the positions of precursor and mature 
were quantified by densitometry with a Helena Laboratories Quick 
Scan  R + D to calculate the percent of maltose-binding protein that 
is mature. The data were adjusted for the removal of 3 of the 9 
methionines when precursor is matured. 
Purification of Maltose-binding Protein Species-The matured 
forms of wild-type maltose-binding protein, MalE VSG, MalE A276G, 
and MalE Y283D,  were purified from strains harboring plasmids that 
carried the appropriate maZE gene. All four malE alleles encoded a 
wild-type leader peptide. Mature MalE G19C was purified from a 
strain carrying the double mutation, malE M(-8)R, malE G19C on 
the chromosome, after induction by maltose. The defective leader 
allows sufficient export to purify substantial quantities of mature 
protein. MalE D55N and MalE T3451, expressed from alleles encod- 
ing wild-type leaders, were purified from strains carrying malF-1; 
therefore induction by maltose was not required. The proteins were 
purified by affinity chromatography using an amylose resin as de- 
scribed (23). The proteins were concentrated by ultrafiltration 
through an Amicon membrane filter (YM-10) and analyzed by elec- 
trophoresis on sodium dodecyl sulfate, 15% polyacrylamide gels to 
verify the purity. The concentrations of the proteins was determined 
by the method of Lowry et al. (24) using bovine serum albumin as a 
standard. 
Fluorescence Spectroscopy-The urea-induced unfolding or refold- 
ing of the maltose-binding protein species was monitored by the 
decrease or increase of the intrinsic fluorescence of tryptophan, 
respectively. Fluorescence intensity was measured using a Shimadzu 
RF-540 fluorescence spectrophotometer with an excitation wave- 
length of  295 nm  (slit width, 2 nm)  and  an emission wavelength of 
344 nm (slit width, 5 nm). All fluorescence measurements were made 
at 25 “C. 
Equilibrium Studies of Folding-Native proteins (5 pg)  were added 
to varying concentrations of urea in  3 ml of 10 mM HEPES  (pH 7.6 
adjusted with KOH),  and  the fluorescence intensity of each sample 
was measured after equilibration at 25 “C. The final concentration of 
urea in each sample was confirmed by measuring the index of refrac- 
tion. The urea solutions were degassed, filtered, and used within a 
day. 
Kinetic Studies of Folding-Unfolding reactions were initiated by 
adding approximately 5 pg of native protein to a solution of urea in 
10 mM HEPES  (pH 7.6) (final volume, 3 ml) held in  a  stirred cuvette 
in the chamber of the spectrophotometer. The addition of protein 
was made manually with a plastic plunger. The time that elapsed 
between addition of the sample and  the first recording of fluorescence 
intensity was approximately 3 s. For the series of refolding studies, 
maltose-binding protein was unfolded by incubation for over 2 h in 6 
M urea in 10 mM HEPES  (pH 7.6). Folding was initiated by addition 
of the denatured protein (approximately 5 pg) to a predetermined 
volume of a solution of buffered urea such that  the final  urea concen- 
tration was as indicated for each experiment. The relaxation time to 
achieve the new equilibrium was extracted from a  plot of the log of 
the change in fluorescence versus time. 
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Analysis of Folding Data-Equilibrium unfolding data obtained 
from the changes in the fluorescence  intensity were fit  to  the following 
two-state model, 
Kapp 
N e U  (Model 1) 
where N is the  native  protein, U is the unfolded  protein, and Kapp = 
[U]/[N]. It can be shown that Fapp, the apparent fraction of the 
unfolded  form, is as follows. 
Fapp = Kapp/(l + Kan) (Eq. 1) 
The equation Kapp = exp(-(ApHZ0 + A[urea])/RT) (25, 26) was 
substituted into the above equation  to  calculate  and A values, 
where A p H @  is the free energy difference in the absence of denatur- 
ant, and A is a parameter that describes the cooperativity of the 
unfolding  transition (27). 
For comparison of the wild-type and mutant protein data, the 
observed  changes in fluorescence  signals  were converted to an appar- 
ent  fraction of unfolded protein, Fan, such that, 
Fapp =   YO^ - Y N ) / ( ~ u  - YN) (Eq. 2) 
where Yob. refers to  the observed fluorescence intensity at a particular 
urea concentration,  and Y N  and YU refer to  the  calculated  values for 
the  native  and  unfolded  forms,  respectively, at the same denaturant 
concentration. A linear dependence of Yob. on the urea  concentration 
was observed in the pre- and  posttransition base-line regions.  Linear 
extrapolations from these base lines yielded the  concentration inde- 
pendent values for YNo and Yuo. Concentration  dependent  values for 
Y N  and Yu can be calculated from the following  equations, 
Y N  = YNo + MN[urea]  0%. 3) 
Yu = Yuo + Mu[urea]  (Eq. 4) 
where MN and Mu are the slopes of the pre- or posttransition regions 
(native and unfolded forms,  respectively) (28). The  above  equations 
were combined to  obtain a single equation for the dependence of the 
fluorescence intensity on the  denaturant  concentration. 
Yoh = ( YNO + MN[urea]) + [exp(-(ApHfl 
- A[urea])/RT)/(l + exp(-(AGoHzO - A[urea]/RT))] (Eq. 5) 
X [Yuo + Mu[urea]) - ( Y N o  + MN[urea])] 
The  observed  data were fit  to  this  equation  with a nonlinear  least 
squares program NLIN (SAS Institute,  Inc., Cary, NC). The  midpoint 
of the unfolding  transition  curve, C, was obtained by solving for the 
urea  concentration when Fapp = 0.5. 
RESULTS 
Identification of Aminoacyl Changes That Slow Folding in 
Vivo-The scheme that we have used to select for changes in 
the  step  that determines the  rate of folding in vivo is based 
on our  current  understanding of the mechanism of protein 
export in E.  coli. Proteins  that  are xported to  the periplasmic 
space are synthesized as precursors containing  amino-termi- 
nal extensions, the leader peptides. These precursors must 
cross the cytoplasmic membrane before they acquire stable 
tertiary  structure (22). Following synthesis of the precursors, 
there is a kinetic partitioning between the pathway of folding 
and  the pathway of export. One of several functions of the 
leader peptide is to retard folding of the mature moiety 
allowing the precursor to engage the export  apparatus. The 
leader is also involved in mediating transfer across the mem- 
brane. We have shown previously that a decrease in  rate along 
the productive pathway, resulting from a defective leader 
sequence that mediates slow translocation across the mem- 
brane,  can be partially overcome  by slowing the folding of the 
precursor and  thereby increasing the time  during which that 
polypeptide is competent to enter the export pathway (23, 
29). The identification of mutations in malE, the gene encod- 
ing maltose-binding protein, that slow folding was accom- 
plished by selection for intragenic suppressors of the export 
defect caused by a  mutational change in  the leader peptide 
(the precursor MalE A(-13)E carries  a leader with the alanyl 
residue at position -13 changed to a glutamyl residue). This 
export-defect leader retards folding allowing entry into the 
export pathway but is very inefficient in promoting transfer 
through the membrane. Strains producing MalE A(-13)E 
contain less than 10% of the normal amount of maltose- 
binding protein in the periplasm and grow poorly  on maltose. 
Strains carrying suppressors that enhance the ability to utilize 
maltose can be distinguished from the export-defective parent 
strain by a difference in color of the colonies grown on 
MacConkey indicator plates  containing maltose. If the level 
of maltose-binding protein in the periplasm is increased to 
approximately 20% of wild-type levels, the growth on maltose 
is normal (30). Therefore suppression can be achieved not 
only by increasing the efficiency  of export but also simply by 
producing 2- or %fold  more precursor than normal. In fact, 
most of the suppressors initially identified were of the class 
that increased the level of expression of the malE allele. To 
identify the mutations of interest for this study, that is those 
that affect folding, the export kinetics of the candidate strains 
were examined. The screening yielded  two intragenic muta- 
tions with alterations  in the portion of the gene encoding the 
mature region, malE Y283D (the codon for the residue at 
position 283 was changed from TAT to GAT) and malE 
A276G (GCG to GGG at  the position encoding residue 276). 
One of these mutations, malE Y283D, is the same as a 
mutation isolated previously as malE2261 in  a similar search 
for intragenic suppressors (31). Both  mutations malE  Y283D 
and malE A276G occurred spontaneously; attempts to in- 
crease the number of suppressors by mutagenizing the portion 
of the gene encoding the mature region of the protein were 
unsuccessful (see "Experimental Procedures"). 
Both  substitutions improved the export of maltose-binding 
protein that carried the defective leader (Fig. 2 A ) .  Newly 
synthesized polypeptides were labeled by addition of [35S] 
methionine to exponentially growing cells followed 15 s later 
by addition of an excess of nonradioactive methionine. Incu- 
bation of the culture was continued, and samples were with- 
drawn at  the times indicated. Maltose-binding protein was 
immunoprecipitated from the cell extracts,  and the distribu- 
tion of radioactivity between the precursor and  mature forms 
was assessed by a combination of sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis and fluorography. The 
wild-type precursor maltose-binding protein was rapidly and 
quantitatively converted to  the mature form with a tlIP of less 
than 30 s. The precursor species carrying the defective leader, 
MalE A(-13)E, was  very poorly exported. In 10 min less than 
10% of the precursor was processed. The presence of either 
second suppressing mutation which changed a residue in the 
mature moiety increased the amount of precursor processed 
so that by 10 min 48% of MalE A(-13)E, A276G was  in the 
mature form. As published previously (31), 16% of MalE 
A(-13)E, Y283D was processed within 10 min. Similar anal- 
yses of export kinetics showed that both malE Y283D' and 
malE A276G could also suppress the defect caused by the 
leader mutation, malE T(-11)K (data not shown). Neither 
suppressor could restore export of precursors carrying the 
substitution M(-9)R (data  not shown). MalE M(-9)R shows 
no processing of precursor, whereas the other defective leaders 
support 10-30% of the normal level of processing. This  pat- 
tern of suppression is consistent with the notion that  retar- 
dation of folding can increase the probability that  at any given 
time the precursor is competent for export, but it cannot 
restore export if the translocation  step is completely blocked. 
J. Weiss,  personal communication. 
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FIG. 2. Kinetics of processing of maltose-binding protein 
species. The experiment was performed as described under  “Exper- 
imental Procedures.” A ,  the kinetics of processing of wild-type malt- 
ose-binding protein (0), maltose-binding protein carrying a change 
in the leader, MalE A(-13)E (A), maltose-binding protein species 
with two changes, one  in the leader and one in the mature region, 
MalE A(-13)E, T345I (O), MalE A(-13)E, Y283D (V), and MalE 
A(-13)E, A276G (W). B ,  the kinetics of processing of maltose-binding 
protein with a defective leader, MalE T(-ll)K (V), and a species 
with two changes, MalE T(-ll)K, V8G (*). Data for wild-type 
maltose-binding protein (0) are taken from A.  
The laboratory of P. J. Bassford, Jr. introduced the ami- 
noacyl substitution VSG into malE by site-directed mutagen- 
esis during  construction of a  restriction  site for other  pur- 
poses. Preliminary observations indicated that export of this 
altered species was less dependent than was that of wild-type 
protein on the bacterial chaperone SecB.2 Such a reduced 
requirement for SecB, which binds precursors and  maintains 
them  in an export-competent  state,  is  consistent with the idea 
that  the polypeptide itself remains  in the competent  nonna- 
tive state longer than does the wild-type protein. If this were 
true  then  the aminoacyl substitution should suppress an ex- 
port defect caused by a  mutated leader. To  test  this idea a 
construct was created that carried both malE T(-ll)K, a 
change rendering the leader inefficient in mediating translo- 
cation  through the membrane, and malE V8G. Analysis of the 
kinetics of export in uiuo shows that  the precursor protein 
carrying both changes was processed more efficiently than 
that carrying the leader mutation alone (Fig. 2B).  Therefore, 
the altered  protein was included in our studies as a species 
that demonstrates slow folding in uiuo. A fourth protein 
species that folds slowly in  vivo, the product of the gene malE 
G19C, was identified in a previous study (16) as an intragenic 
suppressor of the leader mutation malE M(-S) R. 
The folding properties of two additional species of maltose- 
* s. Strobe1 and P. J. Bassford, Jr., personal communication. 
binding protein, MalE T345I and MalE D55N, identified in  a 
selection for altered chemotactic behavior (17), were included 
in  the study to demonstrate that  not every aminoacyl substi- 
tution affects folding. One of these  mutations, malE T3451, 
was also tested for suppression of the leader mutation malE 
A(-13)E. No suppression of the export defect was  observed 
as assessed by the color of colonies on MacConkey plates 
containing maltose or by determination of the kinetics of 
export in uivo (Fig. 2 A ) .  As shown below, the substitution has 
no effect on the  rate of folding in uitro. The lack of suppression 
is consistent with a kinetic partitioning between folding and 
export in uiuo. 
Folding Studies of Purified Proteins by Fluorescence Spec- 
troscopy-The intrinsic fluorescence of maltose-binding pro- 
tein, which contains 8 tryptophanyl residues (Fig. 3; Refs. 32 
and 33), decreases upon denaturation; thus fluorescence spec- 
troscopy can be used to investigate the stabilities  and folding 
properties of the various species of the protein. The species 
of maltose-binding protein that folds within the cell is the 
precursor form. Previous studies using fluorescence spectros- 
copy with purified proteins have shown that  the presence of 
a leader peptide, whether it be a wild-type or an export- 
defective species, slows the folding of both maltose-binding 
protein (23) and ribose-binding protein (29). In addition, for 
the various species of both polypeptides studied previously, 
the retardation of folding exerted by the leader is additive to 
that caused by aminoacyl substitutions in the mature moiety. 
In  the present study, we compared the  rate of folding of the 
precursor form of one of the altered species of maltose-binding 
protein, MalE A(-13)E, A276G, with that of the wild type 
(Table  I).  For the species with two substitutions, the presence 
of the leader retarded the folding 36-fold relative to  the mature 
form. The wild-type leader retarded folding 34-fold relative 
to  the wild-type mature. Whether we compared the relative 
rates of folding of the mature forms or of the precursor forms 
for the two species of maltose-binding protein, the effect of 
the aminoacyl substitution in the mature moiety was the 
same: a 14-fold decrease in the rate of folding. Since the 
simultaneous presence of the leader and  the substituted ami- 
FIG. 3. Stereo view of maltose-binding protein. The position 
of the 8 tryptophanyl residues are shown. The coordinates for the 
1.7-A resolution structure were generously provided by F. Quiocho. 
The figure was generated by the Insight I1 program. 
TABLE I 
Folding of precursor and mature forms of maltose-binding protein 
The refolding was carried out  in 1.85 M urea, 10 mM HEPES  (pH 
7.6) a t  25 “C as described under “Experimental Procedures.” 
Protein suecies T 
S-1 
Precursor MalE wild-type 1,170 
Precursor  MalE A(-13)E, A276G 16,200 
Mature  MalE wild type 34” 
Mature  MalE A276G  442 
“The value for the denaturant-dependent folding reaction was 
extrapolated (see Fig. 5) for comparison with the values of the 
corresponding observed denaturant-dependent folding of the other 
species. The observed T at 1.85 M urea was 91 s-’. 
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noacyl residue demonstrates an additive retardation of folding 
(476-fold), we can conclude that both the leader and the 
substitution interfere with folding at  the same step in the 
pathway. Thus we could study the effects of the aminoacyl 
substitutions on the rate-limiting step in folding using the 
mature species. Use of the mature species offers considerable 
advantages. Not only is it difficult, because of problems of 
aggregation and degradation, to obtain pure precursors in 
quantities sufficient for spectroscopic studies, but also a more 
serious problem lies within the inherent slow folding of the 
precursors. At concentrations of denaturant corresponding to 
the middle portion of the unfolding transition even the mature 
forms fold so slowly that experiments  are difficult (relaxation 
times  can be as long as  15 h). The addition of the leader would 
retard folding another 35-fold making the experiments  im- 
possible; the relaxation time at  the midpoint of the  transition 
would  be expected to be on the order of 21 days. Therefore 
the following in-depth equilibrium and kinetic analyses were 
carried  out with the mature forms. 
Equilibrium Unfolding Transitions for the Various  Species 
of Maltose-binding Protein-An equilibrium study of the urea- 
induced reversible unfolding of the wild-type protein (Fig. 4) 
shows a smooth sharp  transition between folded and unfolded 
states with a midpoint at 3.5 M urea. The urea-induced 
unfolding transitions of the six altered species of maltose- 
binding protein were compared with the  transition of the wild 
type. The four substitutions that suppressed export defects 
rendered the polypeptide less stable than wild type (Fig. 4 
and  Table 11). Of the two substitutions that affect the che- 
motactic properties of maltose-binding protein,  but  are  not 
necessarily expected to alter  the rate of folding, one had no 
effect on  stability  (MalE D55N) and  the  other (MalE  T345I) 
shifted the midpoint of the transition to a higher concentra- 
tion of urea relative to  the wild-type protein, indicating in- 
creased stability (Fig. 4 and Table 11). 
Since the object of our  study was to determine whether the 
step  that limits the  rate of folding in vivo is the same as  that 
which limits the  rate in vitro, it was necessary not only to 
carry out equilibrium studies, which address the stability of 
proteins, but also to determine directly the effects of the 
aminoacyl substitutions on folding and unfolding rates. 
Kinetic Studies of the Folding Reactions-Purified protein, 
either  in the native (no urea  present)  or in the unfolded state 
[Ureal (MI 
FIG. 4. Equilibrium transition curves for unfolding of malt- 
ose-binding protein species. Experimental  details and analysis of 
data are described under “Experimental Procedures.” 0, wild-type 
maltose-binding protein; *, MalE V8G; A, MalE G19C; 0, MalE 
A276G; V, MalE Y283D; 0, MalE D55N; B, MalE T345I. The solid 
lines indicate the fit to a  two-state model. 
TABLE I1 
Thermodynamic  parameters for species of maltose-binding  protein 
The parameter A is the dependence of the free energy difference 
on urea concentration. Errors are 95% confidence intervals from 
nonlinear  least  squares fits. C, is the midpoint of the urea-induced 
unfolding transition. The errors  in midpoints are f0.02 M. 
Protein -A C, (urea) A A G  
kea1 mot’ (M, urea)” M kcal mot’ 
Wild type 2.7 f 0.3 3.50 
MalE V8G 3.6 f 0.6 3.14 1.1 
MalE G19C 2.8 f 0.2 2.66 2.3 
MalE A276G 3.2 f 0.3 2.98 1.5 
MalE Y283D 3.3 -+ 0.4  2.44  3.2 
MalE T345I 2.4 f 0.4  3.79
MalE D55N 
-0.7 
3.1 * 0.4  49 0 
“The change in stability by mutation is determined as AAG = 
( - A )  AC, where AC, is the difference between the value of C, for 
wild-type and altered species and ( - A )  is the average value of -A. A 
negative value for AAG corresponds to  an increase in stability due to 
the alteration (48). 
(6 M urea present), was subjected to a rapid change in condi- 
tions that required the protein to achieve a new equilibrium 
mixture of native  and unfolded states. The relaxation time to 
reach the new equilibrium was determined by monitoring the 
change in fluorescence with time. A series of experiments was 
carried out for each species of maltose-binding protein, and 
the results  are displayed in plots of the relaxation time as  a 
function of the final concentration of urea (Figs. 5-7). For all 
seven proteins studied the unfolding reaction is described by 
a single kinetic phase that accounts for greater than 90% of 
the expected change in fluorescence intensity. The rate-lim- 
iting step that we monitor in unfolding is from the native 
state  to whatever species follow it. In interpreting the  data 
for refolding, we have assumed that  the refolding of all species 
has  as the end  point the native folded form. This is clearly 
demonstrated for the wild-type species, since the relaxation 
times for unfolding and refolding meet smoothly at  the inflex- 
ion point (Fig. 5), indicating that the refolding reactions 
observed are  the reverse of the rate-limiting  step in unfolding 
which has  as  its  starting  point the native state  (14). Kinetic 
data could not be generated at urea concentrations near the 
inflexion point for one of the altered species (MalE Y283D) 
because of artifacts that are likely to result from aggregation 
of intermediates  during the very  slow folding phase. However, 
the relaxation time to reach equilibrium when shifting from 
no denaturant (i.e. native  state)  into  concentrations of urea 
so low that folding is favored falls on the line described by 
refolding from the denatured  state;  thus, in this case too the 
folding we observe is the reverse of unfolding (Fig. 7). 
Refolding of the wild-type protein is described by three 
kinetic phases (Fig. 5). A burst  phase accounts for approxi- 
mately 20% of the amplitude. The remaining 80% of the 
change in the fluorescence intensity is distributed between 
two refolding phases which we resolve. The relative ampli- 
tudes of these  phases  are 0.6 for the slower phase and 0.4 for 
the faster when refolding is observed at final concentrations 
of urea below  1.75 M. In  this range, the relaxation times  are 
independent of the concentration of denaturant ( r l ,  20 s; rI’, 
60 5). Above 1.75 M urea, the relaxation times for refolding 
increase with increasing concentration of urea, and in this 
region the refolding phases have relative amplitudes of  0.7 for 
the slow phase and 0.3 for the fast. Both the slow and  fast 
phases connect smoothly with the corresponding denaturant- 
independent folding phase as well as with the unfolding phase. 
The two species that carry  alterations  unrelated  to  the com- 
petence of the polypeptide for export have no effect on refold- 
ing (Fig. 6). One of these species, MalE T3451, displayed a 
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FIG. 5. The urea dependence of the relaxation times for 
unfolding and refolding of  the  wild-type maltose-binding pro- 
tein. The relaxation times for refolding (open symbols) and unfolding 
(closed symbols) were obtained as described under “Experimental 
Procedures.” Each refolding reaction has a slow (0) and a fast (@) 
phase. The lines are  drawn to aid the eye. 
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unfolding and refolding of MalE D55N and MalE T345I. The 
FIG. 6. The urea dependence of the relaxation times for 
relaxation times for refolding (open symbols) and unfolding (closed 
symbols) were obtained as described under “Experimental Proce- 
dures.” 0, MalE D55N ., MalE T345I. The dashed lines indicate the 
relaxation times of wild-type maltose-binding protein taken from Fig. 
5  for comparison. 
decrease in the  rate of unfolding relative to  the wild type, 
which would account for the increase in relative stability 
observed in the equilibrium study. 
The four species of maltose-binding protein with aminoacyl 
substitutions that improved export, and thereby  are assumed 
of MBP in Vivo and in  Vitro 
to slow folding i n  uiuo, refold  more  slowly than wild type i n  
vitro as well (Fig. 7). In  addition, the refolding at each con- 
centration of denaturant  is described by two kinetic phases 
in contrast to the three phases observed in the wild-type 
species. A burst phase accounts for approximately 20-30% of 
the amplitude with the recovery of the remainder of the 
fluorescence intensity described by one relaxation time. 
DISCUSSION 
There is currently much discussion concerning the relation- 
ship of folding pathways delineated in vitro to pathways of 
folding taken i n  uiuo, which are difficult to study directly (34, 
35). In order to compare the i n  vivo folding pathway of 
maltose-binding protein with the spontaneous folding as- 
sessed by tryptophanyl fluorescence, we have taken advantage 
of the inherent  relation between the  rate of folding of the 
polypeptide in  the cytoplasm and  its ability to be productively 
exported to  the periplasm of E. coli. The entry of maltose- 
binding protein  into the export pathway is mediated by its 
interaction with the chaperone SecB (36-38). Although the 
natural ligand for SecB is the precursor form of maltose- 
binding protein, which carries an amino-terminal extension, 
the leader sequence, the selective binding of the precursor is 
not  the result of direct recognition of that leader (39). Rather, 
the leader slows the folding of the polypeptide, thereby allow- 
ing SecB to bind sites that would be rapidly buried in the 
folded mature form (39-41). The binding to SecB is readily 
reversible, thus in uiuo, there is a kinetic partitioning between 
productive export and the folding of the precursor. Once 
folded, the precursor cannot  enter the export pathway. The 
leader sequence has, in addition to its role to retard folding, 
a second function during the translocation  step at  the mem- 
brane. Altered leader sequences have been identified that 
effectively retard folding allowing rapid delivery to  the mem- 
brane but  are very inefficient in promoting translocation (23, 
1 o4 
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FIG. 7. The urea dependence of the relaxation times for 
unfolding and refolding of the species of maltose-binding 
protein that suppress export defects. The relaxation times for 
refolding (open symbols) and unfolding (closed symbols) were obtained 
as described under “Experimental Procedures.” A, MalE G19C; 0, 
MalE A276G; Sr, MalE V8G V, MalE Y283D. The dashed lines 
indicate the relaxation times of wild-type maltose-binding protein 
and are taken from Fig. 5  for comparison. 
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42). According to the model of kinetic partitioning such 
defects could be partially overcome by alterations in the 
polypeptide that  further reduce the  rate of folding. It has been 
demonstrated that selection for increased export of precursors 
carrying defective leaders does allow isolation of species of 
both ribose-binding protein (29) and maltose-binding protein 
(23) that have altered folding properties. Here  in an extended 
analysis of maltose-binding protein we have examined four 
species identified as folding slowly in vivo: three species were 
selected as suppressors of export defects and one species had 
a  substitution introduced for other purposes and was subse- 
quently found to partially overcome export defects. All four 
species fold more slowly in vitro than does the wild-type 
protein. We also analyzed the spontaneous folding in vitro of 
two altered species that were selected in viuo for properties 
that  are  not expected to be related to folding. As anticipated 
the substitutions  in  these polypeptides did not  alter  the  rate 
of folding assessed i n  vitro. We conclude that  the rate-deter- 
mining step  in the folding of maltose-binding protein is the 
same in  the pathway taken in the complex milieu of the cell 
as it is in the spontaneous folding pathway taken by the 
purified polypeptide. Thus, an analysis of the i n  vitro folding 
reaction allows detailed understanding of the step that limits 
the rate of folding i n  vivo. 
The  data demonstrating  three  kinetic  phases  in refolding 
of the wild-type protein,  MalE  T345I and MalE D55N, can 
be rationalized by a model for folding that  has two parallel 
pathways (Fig. 8), each with two intermediates I1 and I2 or 11’ 
and I*’. Unfolding is governed by the  transition from N to IZ 
or Iz’. Both  reactions are proposed to pass  through the same 
transition  state to account for the single kinetic phase ob- 
served for unfolding. Refolding proceeds through a burst 
phase followed  by the conversion of Il (or I,’) to Iz  (or  Iz’), 
which is  rate-limiting at urea  concentrations below 1.75 M. 
Since  these reactions are  independent of the concentration of 
denaturant, they are likely to involve isomerization of the 
polypeptide backbone (43,44). Above 1.75 M, the folding rate 
is determined by the conversion of I2  or Iz’ to N. The relaxa- 
tion  times of these reactions decrease as  the concentration of 
urea decreases, indicating that these  steps involve the folding 
of the polypeptide. We have proposed that  the parallel chan- 
nels are connected by interconversion at  the states U, I,, and 
12, because the proportion of the amplitude accounted for by 
the kinetic phases is dependent  on  whether the  rate of folding 
is limited by I1 to Iz (isomerization) or by Iz to N (folding). 
We cannot presently eliminate an alternative model in which 
all four of the intermediate species lie along one pathway. In 
either case, the model for folding of the altered species is 
simpler, since one of the kinetic phases  disappears and  the 
model collapses to one channel comprising two intermediate 
states: U - I1 t, Iz c, N, with U t, I1 representing  a collapse 
















FIG. 8. A model of  the  folding  pathway for maltose-binding 
protein. A detailed description is provided in the  text.  The values of 









FIG. 9. Reaction coordinate diagram for the folding reac- 
tion of maltose-binding protein. 
tion,  and I2 t, N the denaturant-dependent folding reaction. 
It is of interest to note that folding studies of the wild-type 
species carried out in guanidinium chloride or in urea with 
the addition of  KC1 can also be accounted for by one channel 
of folding with two intermediates. Thus it seems that the 
ionic strength  or  the chloride ion affects the stability of the 
two intermediates or of their corresponding transition  states. 
We shall discuss the equilibrium and kinetic studies of the 
altered species in  terms of this simplified model. The reaction 
U c, 11, which accounts for 20-30% of the  total difference in 
fluorescence between U and N, is over within the time re- 
quired to initiate the reaction manually. Attempts to resolve 
the reaction for the wild-type maltose-binding protein using 
stopped-flow fluorescence spectroscopy indicated that  it oc- 
curs within 8 ms, the dead-time of the in~trument.~ The 
intermediate formed is likely to represent a collapsed state 
that has considerable secondary structure, since analysis of 
the wild-type species by stopped-flow circular dichroic spec- 
troscopy showed acquisition of substantial ellipticity at 220 
nm during the initial burst phase rea~tion.~  The r actions 
that we follow by fluorescence spectroscopy with manual 
mixing are  the much slower reactions from 11, the collapsed 
state intermediate, to IZ or from Iz to the native  state, N. The 
four aminoacyl substitutions that slow the folding and  act to 
enhance  export in vivo do not significantly alter  the rate of 
unfolding. In  terms of a reaction coordinate diagram (Fig. 9) 
describing the reversible folding reaction (for simplicity of 
discussion we shall  omit the isomerization step I, t, 12), we 
see that this effect can result from either an increase in 
stability of I2 relative to  the  transition  state (TS) or a decrease 
in  stability of the  transition  state  that is carried over to  the 
native state. In either case, the activation energy for folding 
is increased with no effect on the rate of the unfolding 
reaction. Any increase in the energy level of N without an 
equal change in the energy level of U would require that  the 
altered  protein be less stable  than  the wild type. Equilibrium 
studies show that  this  is  true for all of the four altered species. 
Thus for these species it is likely that  the transition  state  and 
the corresponding native  state  are destabilized to  the same 
extent. 
Examination of the three-dimensional  structure of maltose- 
binding protein, resolved to 1.7 A by x-ray crystallography,6 
shows that although the residues that slow the rate of folding 
are widely spread within the primary sequence (at positions 
8, 19, 276, and 283), they  are  all found in the same element 
L. Randall, C. Mann,  and C. R. Matthews, unpublished results. 
F. Quiocho, personal communication. 
‘ C. Mann  and C. R. Matthews, personal communication. 
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of structure in the native state (Fig. 10). This observation 
supports the idea that formation of this element of structure 
is  rate-limiting  and that  the  structure of the  transition  state 
for this reaction is near-native. Maltose-binding protein is a 
member of a family of soluble periplasmic binding proteins 
that have similar structures.  They  are.bilobate a-@ proteins 
with the ligand-binding site in a cleft separating two globular 
domains (45, 46). The substitutions that limit the rate of 
folding for maltose-binding protein  are  in the N domain (also 
referred to as domain 1). It is of interest that alterations 
identified by a similar selection scheme as crucial to folding 
for ribose-binding protein  are confined to  the corresponding 
domain of that protein (29, 47). It may be that  the  rate of 
folding of all polypeptides in  the binding-protein family is 
limited by acquisition of structure  in  this domain. 
During the initial stages of protein export, one of the 
functions of the leader peptide is to slow the folding of the 
precursor to render it  competent to engage the export appa- 
ratus (40, 41). As we have discussed, the leader has  its affect 
on the same step  as do the aminoacyl substitutions;  thus, the 
study of folding described here provides insight into  a possible 
mechanism for this  retardation of folding. The amino termi- 
nus of the mature  protein lies near the element of structure 
defined by the aminoacyl substitutions  as crucial in folding. 
In the precursor the leader, which is an extension at the 
amino terminus, might fold into this element and thereby 
interfere with the rate-limiting  step. 
The comparative study of folding in uiuo and i n  uitro 
presented here cannot help us  in  determining the exact rate 
constants of the folding reactions i n  uiuo. Thus  this type of 
analysis does not directly address the question of whether in 
vivo chaperones act  as  catalysts by decreasing the activation 
energy of folding reactions. What  can be concluded is that  in 
the case of maltose-binding protein  interaction with cellular 
components does not actively direct the polypeptide along a 
folding pathway that includes an intermediate  for the rate- 
limiting step different from that present in the spontaneous 
folding pathway. Both in the complex milieu of the cell and 
in a purified system the same step  determines the rate. Thus 
B 
FIG. 10. Aminoacyl residues crucial  for folding. A ,  location 
within the native structure. B, element of structure enlarged. The 
coordinates for the 1.7-A resolution structure were generously pro- 
vided by F. Quiocho. The native aminoacyl residues at  the location 
of changes are represented. The figure was generated by the Insight 
I1 program. 
studies carried out in uitro can provide insight into  the  inter- 
mediates involved in the acquisition of proper native struc- 
ture. In addition, in the case of exported proteins such as 
maltose-binding protein and ribose-binding protein such stud- 
ies may help to elucidate the  structural  state  that is competent 
for translocation  through the membrane. 
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